Evidence map›Paper›PMID 26195812›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus.

Inge E A Flesch, Natasha A Hollett, Yik Chun Wong, Bárbara Resende Quinan, Debbie Howard, Flávio G da Fonseca, David C Tscharke

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Viral Vector-BasedVaccines · 2024
    Article
  3. Article
  4. Direct Priming of CD8Journal of virology · 2021
    Article
  5. Surprisingly Effective Priming of CD8Journal of virology · 2020
    Article
  6. Vaccines · 2020
    Article
  7. Article
  8. Most viral peptides displayed by class I MHC on infected cells are immunogenic.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inge E A FleschResearch School of Biology, Australian National University, Canberra, Australian Capital Territory 2601, Australia;
Natasha A HollettResearch School of Biology, Australian National University, Canberra, Australian Capital Territory 2601, Australia;
Yik Chun WongResearch School of Biology, Australian National University, Canberra, Australian Capital Territory 2601, Australia;
Bárbara Resende QuinanResearch School of Biology, Australian National University, Canberra, Australian Capital Territory 2601, Australia; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil; and.
Debbie HowardJohn Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia.
Flávio G da FonsecaLaboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil; and.
David C TscharkeResearch School of Biology, Australian National University, Canberra, Australian Capital Territory 2601, Australia; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia david.tscharke@anu.edu.au.

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
CD8+ T cell specificity in mouse models of smallpox vaccination and challengeR01AI067401 · NIAID · AUSTRALIAN NATIONAL UNIVERSITY · PI TSCHARKE, DAVID CARL · 2006 to 2008
$736k
NIAID NIH HHS R01 AI067401NIAID NIH HHS U19 AI100627
6 · The paper itself

Abstract

CD8(+) T cells that recognize virus-derived peptides presented on MHC class I are vital antiviral effectors. Such peptides presented by any given virus vary greatly in immunogenicity, allowing them to be ranked in an immunodominance hierarchy. However, the full range of parameters that determine immunodominance and the underlying mechanisms remain unknown. In this study, we show across a range of vaccinia virus strains, including the current clonal smallpox vaccine, that the ability of a strain to spread systemically correlated with reduced immunodominance. Reduction in immunodominance was observed both in the lymphoid system and at the primary site of infection. Mechanistically, reduced immunodominance was associated with more robust priming and especially priming in the spleen. Finally, we show this is not just a property of vaccine and laboratory strains of virus, because an association between virulence and immunodominance was also observed in isolates from an outbreak of zoonotic vaccinia virus that occurred in Brazil.

Indexed as

Amino Acid SequenceAnimalsAntigens, ViralCD8-Positive T-LymphocytesCell LineEpitopes, T-LymphocyteFemaleHost-Pathogen InteractionsImmunodominant EpitopesInterferon-gammaMice, Inbred C57BLSmallpox VaccineSpecies SpecificitySpleenVacciniaVaccinia virusAntigens, ViralEpitopes, T-LymphocyteImmunodominant EpitopesInterferon-gammaSmallpox Vaccine

Identifiers

PMID26195812
PMCPMC4546862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.